Search
Maravai LifeSciences Holdings Inc
MRVIAdd to Watchlist
6.570USD
-0.180-2.67%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.70BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Maravai LifeSciences Holdings Inc is 7.40, ranking 294 out of 385 in the Biotechnology & Medical Research industry. The average price target is 4.00, with a high of 5.00 and a low of 2.00.
Analyst Rating
Based on
9
analysts
Buy
Current Rating
5.900
Target Price
-10.20%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Maravai LifeSciences Holdings Inc
MRVI
9
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Maravai LifeSciences Holdings Inc's expected revenue for the next quarter?
Maravai LifeSciences Holdings Inc's expected revenue is 48.68M.
What is Maravai LifeSciences Holdings Inc's price target?
Analysts forecast that Maravai LifeSciences Holdings Inc's price target is USD 4.00, with the highest forecast at USD 5.00 and the lowest forecast at USD 2.00.
How have Maravai LifeSciences Holdings IncMRVI's recent earnings per share performed?
The market expectation was USD -0.03, while Maravai LifeSciences Holdings IncMRVI's earnings per share (EPS) for the previous quarter was USD -0.25. EPS for the next quarter is expected at USD -0.04.
What is the analyst rating for Maravai LifeSciences Holdings Inc?
Based on the ratings of Maravai LifeSciences Holdings Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.